Any healing peptide's timeline follows the biology of wound repair itself, which unfolds in three well-characterised, overlapping phases: an inflammatory phase in the first 24 hours to a week, a proliferative phase from roughly day 3 to day 14 where new tissue and blood vessels form, and a remodelling phase that runs from around day 7 out to a year, where collagen reorganises and tensile strength is restored.
Mapped onto that biology, most research protocols report early, localised effects — reduced pain and inflammation at the injury site — within the first two to three weeks, roughly tracking the inflammatory-to-early-proliferative window. Broader functional improvements (mobility, strength, range of motion) tend to emerge over weeks three to six, and full tissue remodelling for chronic or more severe injuries can extend to 8–12 weeks.
Individual variation is substantial — injury severity, consistency of protocol, and overall health all shift this timeline meaningfully, and it's worth noting that neither peptide has completed the large-scale human trials needed to establish a validated, standardised recovery timeline.
Study-backed guides, dosing protocols, and the full research peptide collection — all in one place.